DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

234.90 7.66 (3.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $234.90 3.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $228.59
Previous Close $227.24
Daily Range $228.40 - $236.02
52-Week Range $111.41 - $263.81
Market Cap $80.5B
P/E Ratio 93.51
Dividend (Yield) $0.00 (0.0%)
Volume 1,812,255
Average Daily Volume 1,963,938
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary Rss Feed

The Berkshire Hathaway of Biotech Strikes Again

Valeant Pharmaceuticals adds to its growing portfolio of products with the purchase of Sprout Pharmaceuticals. Find out what's made Valeant such a great stock to own, and what investors should be monitoring going forward.

Sucampo to Acquire R-Tech Ueno for About $278 Million

Sequoia Fund Comments on Valeant Pharmaceuticals

Glenn Greenberg Acquires Two New Stakes

Valeant Pharmaceuticals' (VRX) Charts Read Like a Textbook Bull

Exelixis' Cancer Drug Gets Breakthrough Therapy Status

Epizyme (EPZM) Gains as Oncology Candidate Advances

Valeant Pharmaceuticals: Good Or Bad?

Lou Simpson Boosts Stake in Charles Schwab

Vital Therapies Hit By Disappointing Data on Liver Drug

Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter

See More VRX News...

VRX's Top Competitors

VRX $234.90 (3.37%)
Current stock: VRX
JNJ $96.22 (1.17%)
Current stock: JNJ
NVS $98.64 (1.55%)
Current stock: NVS
RHHBY $34.85 (1.40%)
Current stock: RHHBY